NCT06021834

Brief Summary

This is a prospective study. The aim of this study is to investigate the effect of exercise retraining on cardiorespiratory parameters, postural balance, sociopsychological variables, and cognitive function in subjects with Parkinson's disease. There will be two measurement sessions, one pre-intervention and one post-intervention (measuring cardiorespiratory parameters, evaluating dynamic and static postural balance, and assessing cognitive function).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P50-P75 for not_applicable parkinson-disease

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable parkinson-disease

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 30, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 1, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 8, 2023

Completed
Last Updated

September 1, 2023

Status Verified

August 1, 2023

Enrollment Period

29 days

First QC Date

May 30, 2023

Last Update Submit

August 28, 2023

Conditions

Keywords

"Parkinson Disease""cognitive function""postural balance""physical rehabilitation"

Outcome Measures

Primary Outcomes (4)

  • Cardiorespiratory Parameters

    Cardiorespiratory Parameters will be assessed using the six-minute walk test (6MWT).

    There will be two measurement sessions, one pre-intervention and one post-intervention (After 12 week for each patient)

  • Postural Balance

    Postural balance will be assessed using the Timed Up and Go test (TUG) and stabilometry platform

    There will be two measurement sessions, one pre-intervention and one post-intervention (After 12 week for each patient)

  • Depression

    The depression variable will be assessed through Beck Depression Inventory-II .

    There will be two measurement sessions, one pre-intervention and one post-intervention (After 12 week for each patient)

  • Cognitive Function

    Cognitive function will be evaluated using the Montreal Cognitive Assessment score (MoCA) .

    There will be two measurement sessions, one pre-intervention and one post-intervention (After 12 week for each patient)

Secondary Outcomes (1)

  • Strength

    There will be two measurement sessions, one pre-intervention and one post-intervention (After 12 week for each patient)

Study Arms (2)

control group

ACTIVE COMPARATOR

The control group will be invited to attend the program three times per week and will engage in an endurance training program

Other: rehabilitation

experimental group

EXPERIMENTAL

the experimental group will be invited to attend the program three times per week and will participate in a combined endurance training and cognitive training program.

Other: rehabilitation

Interventions

The subjects will be invited to attend the program three times per week.

control groupexperimental group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with Parkinson's disease according to the Movement Disorder Society (MDS) 2015 criteria.
  • Mild to moderate stage according to the Hoehn and Yahr scale.
  • No hearing or visual impairments that could hinder the integration and implementation of the rehabilitation protocol.
  • Has the ability to communicate and walk.
  • Patient has been stable on treatment for 3 months.

You may not qualify if:

  • A contraindication to engaging in cardiovascular physical activity
  • A Montreal Cognitive Assessment score (MoCA ) of less than 24.
  • A current psychiatric disorder that could make it difficult or dangerous to adhere to the research protocol.
  • Musculoskeletal impairments or excessive pain in any joint that could limit participation in an exercise program.
  • Treatment with sedative medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Parkinson Disease

Interventions

Rehabilitation

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

AftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator Ghazoua NAFTI

Study Record Dates

First Submitted

May 30, 2023

First Posted

September 1, 2023

Study Start

September 1, 2023

Primary Completion

September 30, 2023

Study Completion

October 8, 2023

Last Updated

September 1, 2023

Record last verified: 2023-08